Nordic Life Science Platform

FAST-TRACK CHINA ENTRY

- Medtech, Healthtech and Rehabilitation

China Market Access via Fast-track Approval Procedures for Medical Devices & Medicines in Hainan Boao Lecheng International Medical Tourism Pilot Zone

About Us - Mission

The Nordic Life Science Platform (NLSP) has been established to give Nordic medtech, healthtech and rehabilitation companies a more safe, efficient, and easier access to the Chinese healthcare market and to take advantage of the preferential policies and opportunities at Hainan Boao Lecheng International Medical Zone that is part of the newly launched Hainan Free Trade Port that covers all of Hainan Island.

To explore these market opportunities closer, the Nordic Life Science Platform ApS has established a new Partnership with the Danish Life Science Cluster, Innovation Center Denmark in Shanghai, and Trade Council in China with the support of Medtech Denmark.

The initial aim is to match the demand for innovative products and solutions by the hospitals in Hainan Boao Lecheng with the supply of Nordic companies, and that way help develop new sales and export opportunities to China.

Hainan Boao Lecheng serves as a gateway and stepping-stone to the rest of Mainland China's Healthcare Market.

Concept

Concept - One-Stop Service

Although China is the world’s second largest market for both medicine and medical devices, many Nordic life science companies hold back from starting exports or own sales in China because of lack of market knowledge and entry barriers, and therefore perceive it as too difficult and risky. This cuts off Nordic companies from a very large growth market.

To lower the entry barriers, we have gathered a team of experts with many years of know-how and experience from advising and assisting Nordic companies entering and operating in China.

NLSP is a one-stop service platform that reduces the challenges and time to market by offering companies expert advice and supporting services, and by utilizing our local partner network in China.

Offering - Step-by-Step Entry Model

NLSP delivers a Step-by-Step Market Entry Model that supports companies all the way but also give them the option to pull out during the process if they decide the Chinese market is not right for them.

With NLSP and our partner network in China, our experienced team will assist Nordic life science companies to enter China's healthcare market and to take advantage of the opportunities at Hainan Boao Lecheng.

We offer expert advice and supporting services such as project management, legal assistance, market research, matchmaking, IPR protection, venture capital contacts, company set-up, registrations & approvals, and sales channels.

Our Offering

STEP-BY-STEP FLOW CHART

Hainan Boao Lecheng Medical Zone

Boao Lecheng International Medical Tourism Pilot Zone is a designated special medical zone in China that has been granted preferential policies and incentives that aim to create a world-class international medical destination and cluster for advanced medical treatment, professional rehabilitation, medical R&D, and technology innovation in China.

It offers special fast-track approval procedures that make it easier and quicker to register, import, and sell medical devices and medicines in urgent need for use in Hainan Boao Lecheng that are not yet registered in China but approved overseas with a CE mark, FDA license or PMDA approval.

Moreover, it is the only place in China that allows the collection of Real-World Data (RWD) from the use of medical devices and medicines imported under the fast-track approval procedures that can supplement the application for the NMPA registration which can speed up the approval process for selling in the rest of Mainland China.

When fully developed, Hainan Boao Lecheng is planned to cover 25 km2 with a total of 3 km2 of constructed land. Today, 12 hospitals and 5 medical service centres are in operation with 5 new hospitals opening in 2023, and ten more planned. Total construction costs are estimated at RMB 100 billion (USD 16 billion).

When completed, it will provide 12,000 hospital beds, employ 28,500 medical personnel including 3,500 R&D staff, and receive up to 300,000 patients annually. In 2021, a total of 127,300 medical tourists were welcomed.

Hainan